\BOOKMARK [0][-]{chapter.1}{Problemafgr\346nsning}{}% 1
\BOOKMARK [1][-]{section.1.1}{Problemafgr\346nsning}{chapter.1}% 2
\BOOKMARK [0][-]{chapter.2}{Klinisk effekt \(EFF\)}{}% 3
\BOOKMARK [1][-]{section.2.1}{Form\345l}{chapter.2}% 4
\BOOKMARK [1][-]{section.2.2}{HTA sp\370rgsm\345l}{chapter.2}% 5
\BOOKMARK [1][-]{section.2.3}{Metode}{chapter.2}% 6
\BOOKMARK [1][-]{section.2.4}{Statistisk effekt}{chapter.2}% 7
\BOOKMARK [1][-]{section.2.5}{N\370jagtighed}{chapter.2}% 8
\BOOKMARK [1][-]{section.2.6}{Delkonklusion}{chapter.2}% 9
\BOOKMARK [0][-]{chapter.3}{Organisatoriske aspekter \(ORG\)}{}% 10
\BOOKMARK [1][-]{section.3.1}{Form\345l}{chapter.3}% 11
\BOOKMARK [1][-]{section.3.2}{HTA sp\370rgsm\345l}{chapter.3}% 12
\BOOKMARK [1][-]{section.3.3}{Metode}{chapter.3}% 13
\BOOKMARK [1][-]{section.3.4}{Organisatoriske \346ndringer}{chapter.3}% 14
\BOOKMARK [1][-]{section.3.5}{Opl\346ring og vedligeholdelse}{chapter.3}% 15
\BOOKMARK [1][-]{section.3.6}{Delkonklusion}{chapter.3}% 16
\BOOKMARK [0][-]{chapter.4}{Patient- og sociale aspekter \(SOC\)}{}% 17
\BOOKMARK [1][-]{section.4.1}{Form\345l}{chapter.4}% 18
\BOOKMARK [1][-]{section.4.2}{HTA sp\370rgsm\345l}{chapter.4}% 19
\BOOKMARK [1][-]{section.4.3}{Metode}{chapter.4}% 20
\BOOKMARK [1][-]{section.4.4}{Teknologiens p\345virkning p\345 patienten}{chapter.4}% 21
\BOOKMARK [1][-]{section.4.5}{Delkonklusion}{chapter.4}% 22
\BOOKMARK [0][-]{chapter.5}{Etik \(ETH\)}{}% 23
\BOOKMARK [1][-]{section.5.1}{Form\345l}{chapter.5}% 24
\BOOKMARK [1][-]{section.5.2}{HTA sp\370rgsm\345l}{chapter.5}% 25
\BOOKMARK [1][-]{section.5.3}{Metode}{chapter.5}% 26
\BOOKMARK [1][-]{section.5.4}{Patientetik}{chapter.5}% 27
\BOOKMARK [1][-]{section.5.5}{Delkonklusion}{chapter.5}% 28
\BOOKMARK [1][-]{section.5.6}{Perspektivering}{chapter.5}% 29
\BOOKMARK [0][-]{section*.13}{Litteratur}{}% 30
\BOOKMARK [0][-]{chapter.A}{Appendiks: Borgerforl\370b}{}% 31
